lumiflavin

01/01/2019 - "Our study suggests that lumiflavin may be a novel treatment alternative for ovarian cancer and its recurrence."
01/01/2021 - "This study aimed to investigate the synergistic effects of lumiflavin and ionising radiation on ovarian cancer CSCs and explore the association of this metabolite with autophagy. "
01/01/2021 - "Lumiflavin can enhance the effects of ionising radiation on ovarian cancer CSCs. "
01/01/2021 - "Lumiflavin Enhances the Effects of Ionising Radiation on Ovarian Cancer Stem-Like Cells by Inhibiting Autophagy."
01/01/2022 - "In conclusion, lumiflavin reduces the development of the drug resistance of OVCAR-3 cell and increases the sensitivity of CSCs/DDP to DDP by inducing phenotypic differentiation, which may have a potential role in the chemotherapy treatment of ovarian cancer."

09/01/2014 - "Lumiflavin-enhanced growth thus resembled the improved growth that accompanies treatment with antibiotics that deplete Wolbachia, rather than a metabolic advantage provided by the Wolbachia infection. "

01/01/2022 - "Meanwhile, in vivo experiments showed that lumiflavin dose-dependently enhanced the chemotherapy effect of DDP on tumor-bearing nude mice inoculated by CSCs/DDP. "
01/01/2022 - "Lumiflavin Reduces Cisplatin Resistance in Cancer Stem-Like Cells of OVCAR-3 Cell Line by Inducing Differentiation."

06/01/1990 - "Uptake at low (0.1 mumol/L) but not high (20 mumol/L) riboflavin concentrations was inhibited by 50 mumol/L lumiflavin, anoxia, 5 mmol/L indoacetamide, Na(+)-free buffer and low temperature (Q10 = 1.64). "